Foot and mouth disease (FMD) virus: Quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography

Vaccine

Volumn 29, Issue 41, 2011, Pages 7182-7187

  Spitteler, Marcelo A ^a   Fernández, Ignacio ^a   Schabes, Erika ^a   Krimer, Alejandro ^b   Régulier, Emmanuel G ^a   Guinzburg, Mariela ^a   Smitsaart, Eliana ^a   Levy, M Susana ^a  

^a Biogenesis Bago   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA INDUSTRIAL   (Argentina)

Author keywords

140S (146S); FMDV; Foot and mouth disease (FMD) vaccine; Size exclusion chromatography (SEC)

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

ABSORPTION; ACCURACY; ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG MANUFACTURE; FOOT AND MOUTH DISEASE VIRUS; GEL PERMEATION CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SPECTROPHOTOMETRY; ULTRACENTRIFUGATION; VIRUS INACTIVATION; VIRUS PARTICLE; VIRUS STRAIN; WESTERN BLOTTING;

CHROMATOGRAPHY, GEL; FOOT-AND-MOUTH DISEASE VIRUS; TECHNOLOGY, PHARMACEUTICAL; VACCINES, INACTIVATED; VIRAL LOAD; VIRAL VACCINES; VIROLOGY;

EID: 80052488478     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.078     Document Type: Article

References (11)

1. The World Organization for Animal Health (OIE). World Animal Health Information Database (WAHID). 2011. website: [accessed 06.06.11]. http://web.oie.int/wahis/public.php%3Fpage=disease.
2. Grubman M.J., Baxt B. Foot-and-mouth disease. Clin Microbiol Rev 2004, 17(2):465-493.
3. Cartwright B., Chapman W.G., Brown F. Serological and immunological relationships between the 146S and 12S particles of foot-and-mouth disease virus. J Gen Virol 1980, 50:369-375.
4. Doel T.R., Chong W.K.T. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch Virol 1982, 73(2):185-191.
5. Brown F., Cartwright B. Dissociation of foot-and-mouth disease virus into its nucleic acid and protein components. Nature 1961, 192(4808):1163-1164.
6. Foot-and-mouth disease (ruminants) vaccine (inactivated), monograph 0063. Ph. Eur. Suppl. 6.8. Strasbourg, France: Council of Europe; 2010.
7. The World Organisation for Animal Health (OIE). Terrestrial Animal Health Code. Foot and mouth disease, Chapter 2.1.5. 2009. website: [accessed 06.06.11]. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.05_FMD.pdf.
8. Barteling S.J., Meloen R.H. A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV). Arch Gesamte Virusforsch 1974, 45(4):362-364.
9. Lin L.I-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989, 45:255-268.
10. Lin L.I-K. A note on the concordance correlation coefficient. Biometrics 2000, 56:324-325.
11. Barteling SJ. Need for further standardization of the 146-S test as the basis for final foot-and-mouth disease (FMD) vaccine formulation, EUFMD Research Group Meeting, Appendix 17. 1999. website: [accessed 06.06.11]. http://www.fao.org/AG/AGAInfo/commissions/docs/research_group/maison/app17.html.